Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response trial of SABER-Bupivacaine for postoperative pain after open abdominal hysterectomy
2007-006121-26Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (5 arms), sponsored by Takeda. Primary endpoints: Primary efficacy endpoint 1 and Primary efficacy endpoint 2. Started Oct 2008; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2007-006121-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006121-26.